Inflammation and Acinar Cell Dual-Targeting Nanomedicines for Synergistic Treatment of Acute Pancreatitis via Ca2+ Homeostasis Regulation and Pancreas …
Y Wang, X Wang, X Zhang, B Zhang, X Meng, D Qian… - ACS …, 2024 - ACS Publications
Severe acute pancreatitis (AP) is a life-threatening pancreatic inflammatory disease with a
high mortality rate (∼ 40%). Existing pharmaceutical therapies in development or in clinical …
high mortality rate (∼ 40%). Existing pharmaceutical therapies in development or in clinical …
Inflammation and Acinar Cell Dual-Targeting Nanomedicines for Synergistic Treatment of Acute Pancreatitis via Ca2+ Homeostasis Regulation and Pancreas …
Y Wang, X Wang, X Zhang, B Zhang, X Meng, D Qian… - ACS Nano, 2024 - europepmc.org
Severe acute pancreatitis (AP) is a life-threatening pancreatic inflammatory disease with a
high mortality rate (∼ 40%). Existing pharmaceutical therapies in development or in clinical …
high mortality rate (∼ 40%). Existing pharmaceutical therapies in development or in clinical …
Inflammation and Acinar Cell Dual-Targeting Nanomedicines for Synergistic Treatment of Acute Pancreatitis via Ca2+ Homeostasis Regulation and Pancreas …
Y Wang, X Wang, X Zhang, B Zhang, X Meng… - ACS …, 2024 - pubmed.ncbi.nlm.nih.gov
Severe acute pancreatitis (AP) is a life-threatening pancreatic inflammatory disease with a
high mortality rate (∼ 40%). Existing pharmaceutical therapies in development or in clinical …
high mortality rate (∼ 40%). Existing pharmaceutical therapies in development or in clinical …